E-LIB Suche - Ergebnisse für: Zilembo, N.

1

Choosing wisely first line immunotherapy in non-small cell ..:

Proto, C. ; Ferrara, R. ; Signorelli, D....
Cancer Treatment Reviews. 75 (2019) - p. 39-51 , 2019

Link: https://doi.org/10.1016/..

2

Targeted therapy-induced diarrhea: A review of the literatu..:

Pessi, M.A. ; Zilembo, N. ; Haspinger, E.R....
Critical Reviews in Oncology/Hematology. 90 (2014) 2 - p. 165-179 , 2014

Link: https://doi.org/10.1016/..

3

A prospective observational study to evaluate G-CSF usage i..:

Barni, S. ; Lorusso, V. ; Giordano, M....
Medical Oncology. 31 (2013) 1 - p. , 2013

Link: https://doi.org/10.1007/..

4

9014 POSTER DISCUSSION Randomized Phase II Trial of NGR-hTN..:

Gregore, V. ; Zilembo, N. ; Grossi, F....
European Journal of Cancer. 47 (2011) - p. S596 , 2011

Link: https://doi.org/10.1016/..

5

7107 A randomized, prospective, Phase 2 study, with Sorafen..:

Procopio, G. ; Verzoni, E. ; Bracarda, S....
European Journal of Cancer Supplements. 7 (2009) 2 - p. 425 , 2009

Link: https://doi.org/10.1016/..

6

452 Osteoprotegerin (OPG) and osteopontin (OPN): their usef..:

Zilembo, N. ; Martinetti, A. ; La Torre, I....
European Journal of Cancer Supplements. 1 (2003) 5 - p. S138 , 2003

Link: https://doi.org/10.1016/..

7

Short-term effects of anastrozole treatment on insulin-like..:

Ferrari, L. ; Martinetti, A. ; Zilembo, N....
The Journal of Steroid Biochemistry and Molecular Biology. 80 (2002) 4-5 - p. 411-418 , 2002

Link: https://doi.org/10.1016/..

8

c-erbB 2 Serum level as prognostic factor in hormonally tre..:

Zilembo, N. ; Mariani, L. ; Martinetti, A....
The Breast. 11 (2002) 4 - p. 286-294 , 2002

Link: https://doi.org/10.1054/..

9

Markers of bone turnover in metastatic breast cancer (MBC) ..:

Zilembo, N. ; Bajetta, E. ; Martinetti, A....
European Journal of Cancer. 37 (2001) - p. S193-S194 , 2001

Link: https://doi.org/10.1016/..

10

Biological study of anastrozole in post-menopausal advanced..:

Martinetti, A. ; Bajetta, E. ; Buzzoni, R....
European Journal of Cancer. 37 (2001) - p. S197 , 2001

Link: https://doi.org/10.1016/..

11

Safety and activity of Capecitabine in elderly patients wit..:

Procopio, G. ; Bajetta, E. ; Catena, L....
European Journal of Cancer. 37 (2001) - p. S197 , 2001

Link: https://doi.org/10.1016/..

12

Insulin-like growth factor (IGF) components in postmenopaus..:

Ferrari, L. ; Martinetti, A. ; Zilembo, N....
European Journal of Cancer. 37 (2001) - p. S192 , 2001

Link: https://doi.org/10.1016/..

13

Double-blind, randomised, multicentre endocrine trial compa..:

Bajetta, E ; Zilembo, N ; Dowsett, M...
European Journal of Cancer. 35 (1999) 2 - p. 208-213 , 1999

Link: https://doi.org/10.1016/..

14

The minimal effective exemestane dose for endocrine activit..:

Bajetta, E. ; Zilembo, N. ; Noberasco, C....
European Journal of Cancer. 33 (1997) 4 - p. 587-591 , 1997

Link: https://doi.org/10.1016/..

15

The LHRH analogue triptoreline (TAP) with or without the ar..:

Celio, L. ; Martinetti, A. ; Ferrari, L....
European Journal of Cancer. 33 (1997) - p. S155 , 1997

Link: https://doi.org/10.1016/..